nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP1A2—Imiquimod—skin cancer	0.0523	0.0896	CbGbCtD
Caffeine—CYP1B1—Docetaxel—skin cancer	0.0502	0.0859	CbGbCtD
Caffeine—CYP1A1—Dacarbazine—skin cancer	0.0492	0.0842	CbGbCtD
Caffeine—CYP2C8—Vismodegib—skin cancer	0.0468	0.0802	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—skin cancer	0.038	0.0651	CbGbCtD
Caffeine—Skin breakdown—Imiquimod—skin cancer	0.0349	0.285	CcSEcCtD
Caffeine—CYP2C9—Vismodegib—skin cancer	0.0327	0.056	CbGbCtD
Caffeine—ABCB1—Vismodegib—skin cancer	0.0317	0.0543	CbGbCtD
Caffeine—CYP1A2—Vemurafenib—skin cancer	0.0287	0.0491	CbGbCtD
Caffeine—CYP3A4—Temozolomide—skin cancer	0.0274	0.0469	CbGbCtD
Caffeine—CYP3A4—Imiquimod—skin cancer	0.0274	0.0469	CbGbCtD
Caffeine—CYP2D6—Vemurafenib—skin cancer	0.0236	0.0404	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—skin cancer	0.022	0.0376	CbGbCtD
Caffeine—CYP3A4—Vismodegib—skin cancer	0.019	0.0325	CbGbCtD
Caffeine—CYP3A7—Docetaxel—skin cancer	0.0176	0.0302	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0176	0.0302	CbGbCtD
Caffeine—ABCB1—Dactinomycin—skin cancer	0.0166	0.0285	CbGbCtD
Caffeine—CYP2C8—Fluorouracil—skin cancer	0.0166	0.0285	CbGbCtD
Caffeine—CYP3A4—Vemurafenib—skin cancer	0.015	0.0257	CbGbCtD
Caffeine—CYP3A5—Docetaxel—skin cancer	0.0132	0.0226	CbGbCtD
Caffeine—CYP1A2—Fluorouracil—skin cancer	0.0129	0.0221	CbGbCtD
Caffeine—CYP2C9—Fluorouracil—skin cancer	0.0116	0.0199	CbGbCtD
Caffeine—ABCB1—Docetaxel—skin cancer	0.0086	0.0147	CbGbCtD
Caffeine—Necrotizing enterocolitis—Docetaxel—skin cancer	0.00705	0.0577	CcSEcCtD
Caffeine—Necrotising enterocolitis neonatal—Docetaxel—skin cancer	0.00705	0.0577	CcSEcCtD
Caffeine—Necrotising colitis—Docetaxel—skin cancer	0.00577	0.0472	CcSEcCtD
Caffeine—CYP3A4—Docetaxel—skin cancer	0.00515	0.00882	CbGbCtD
Caffeine—PIK3CA—skin epidermis—skin cancer	0.00461	0.0365	CbGeAlD
Caffeine—PIK3CD—nerve—skin cancer	0.00455	0.036	CbGeAlD
Caffeine—PIK3CB—nerve—skin cancer	0.00397	0.0314	CbGeAlD
Caffeine—PIK3CA—nerve—skin cancer	0.00393	0.0311	CbGeAlD
Caffeine—PIK3CD—endothelium—skin cancer	0.00388	0.0307	CbGeAlD
Caffeine—PIK3CD—blood vessel—skin cancer	0.00357	0.0283	CbGeAlD
Caffeine—PIK3CB—endothelium—skin cancer	0.00338	0.0267	CbGeAlD
Caffeine—PIK3CA—endothelium—skin cancer	0.00335	0.0265	CbGeAlD
Caffeine—PIK3CB—hair follicle—skin cancer	0.00332	0.0263	CbGeAlD
Caffeine—PIK3CB—blood vessel—skin cancer	0.00312	0.0247	CbGeAlD
Caffeine—PIK3CA—blood vessel—skin cancer	0.00308	0.0244	CbGeAlD
Caffeine—PRKDC—nipple—skin cancer	0.00275	0.0218	CbGeAlD
Caffeine—PIK3CD—neck—skin cancer	0.00256	0.0202	CbGeAlD
Caffeine—Haemoglobin decreased—Imiquimod—skin cancer	0.00242	0.0198	CcSEcCtD
Caffeine—PIK3CB—nipple—skin cancer	0.00225	0.0178	CbGeAlD
Caffeine—PIK3CA—nipple—skin cancer	0.00223	0.0176	CbGeAlD
Caffeine—RYR1—nipple—skin cancer	0.00223	0.0176	CbGeAlD
Caffeine—PIK3CB—neck—skin cancer	0.00223	0.0176	CbGeAlD
Caffeine—PIK3CA—neck—skin cancer	0.00221	0.0175	CbGeAlD
Caffeine—ADORA1—nerve—skin cancer	0.00208	0.0164	CbGeAlD
Caffeine—ATM—connective tissue—skin cancer	0.00207	0.0163	CbGeAlD
Caffeine—ATM—epithelium—skin cancer	0.00196	0.0155	CbGeAlD
Caffeine—ATM—skin of body—skin cancer	0.00187	0.0148	CbGeAlD
Caffeine—Disseminated intravascular coagulation—Docetaxel—skin cancer	0.00186	0.0152	CcSEcCtD
Caffeine—PIK3CD—connective tissue—skin cancer	0.00183	0.0145	CbGeAlD
Caffeine—Cerebral haemorrhage—Temozolomide—skin cancer	0.00181	0.0148	CcSEcCtD
Caffeine—PIK3CD—epithelium—skin cancer	0.00174	0.0138	CbGeAlD
Caffeine—PIK3CD—skin of body—skin cancer	0.00165	0.0131	CbGeAlD
Caffeine—ADORA2B—nipple—skin cancer	0.00164	0.013	CbGeAlD
Caffeine—PRKDC—mammalian vulva—skin cancer	0.00161	0.0127	CbGeAlD
Caffeine—PIK3CB—connective tissue—skin cancer	0.0016	0.0126	CbGeAlD
Caffeine—PIK3CA—connective tissue—skin cancer	0.00158	0.0125	CbGeAlD
Caffeine—PIK3CB—epithelium—skin cancer	0.00152	0.012	CbGeAlD
Caffeine—ATM—lymphoid tissue—skin cancer	0.00151	0.012	CbGeAlD
Caffeine—PIK3CD—mammalian vulva—skin cancer	0.00151	0.0119	CbGeAlD
Caffeine—PIK3CA—epithelium—skin cancer	0.0015	0.0119	CbGeAlD
Caffeine—Pulmonary oedema—Imiquimod—skin cancer	0.00148	0.0122	CcSEcCtD
Caffeine—ATM—female reproductive system—skin cancer	0.00146	0.0115	CbGeAlD
Caffeine—PIK3CB—skin of body—skin cancer	0.00144	0.0114	CbGeAlD
Caffeine—PIK3CA—skin of body—skin cancer	0.00143	0.0113	CbGeAlD
Caffeine—Malnutrition—Vismodegib—skin cancer	0.00138	0.0113	CcSEcCtD
Caffeine—PIK3CD—lymphoid tissue—skin cancer	0.00134	0.0106	CbGeAlD
Caffeine—Injury—Imiquimod—skin cancer	0.00132	0.0108	CcSEcCtD
Caffeine—PIK3CB—mammalian vulva—skin cancer	0.00132	0.0104	CbGeAlD
Caffeine—RYR1—mammalian vulva—skin cancer	0.0013	0.0103	CbGeAlD
Caffeine—PIK3CA—mammalian vulva—skin cancer	0.0013	0.0103	CbGeAlD
Caffeine—Dry skin—Vemurafenib—skin cancer	0.0013	0.0107	CcSEcCtD
Caffeine—PIK3CD—female reproductive system—skin cancer	0.00129	0.0102	CbGeAlD
Caffeine—ATM—head—skin cancer	0.00122	0.00963	CbGeAlD
Caffeine—PIK3CB—lymphoid tissue—skin cancer	0.00117	0.00925	CbGeAlD
Caffeine—PIK3CA—lymphoid tissue—skin cancer	0.00116	0.00915	CbGeAlD
Caffeine—Irritability—Imiquimod—skin cancer	0.00116	0.00946	CcSEcCtD
Caffeine—PIK3CB—female reproductive system—skin cancer	0.00113	0.00892	CbGeAlD
Caffeine—PIK3CA—female reproductive system—skin cancer	0.00112	0.00882	CbGeAlD
Caffeine—RYR1—female reproductive system—skin cancer	0.00112	0.00882	CbGeAlD
Caffeine—Nervous system disorder—Vismodegib—skin cancer	0.00111	0.00906	CcSEcCtD
Caffeine—CYP1B1—hair follicle—skin cancer	0.0011	0.00872	CbGeAlD
Caffeine—Skin disorder—Vismodegib—skin cancer	0.0011	0.00898	CcSEcCtD
Caffeine—Infestation—Vemurafenib—skin cancer	0.00109	0.00895	CcSEcCtD
Caffeine—Infestation NOS—Vemurafenib—skin cancer	0.00109	0.00895	CcSEcCtD
Caffeine—CYP1A1—skin epidermis—skin cancer	0.00109	0.00864	CbGeAlD
Caffeine—PIK3CD—head—skin cancer	0.00108	0.00854	CbGeAlD
Caffeine—Gastrointestinal disorder—Vismodegib—skin cancer	0.000975	0.00798	CcSEcCtD
Caffeine—Haemoglobin decreased—Docetaxel—skin cancer	0.000966	0.0079	CcSEcCtD
Caffeine—Sepsis—Dactinomycin—skin cancer	0.000959	0.00785	CcSEcCtD
Caffeine—ADORA2B—mammalian vulva—skin cancer	0.000958	0.00758	CbGeAlD
Caffeine—PIK3CB—head—skin cancer	0.000942	0.00745	CbGeAlD
Caffeine—Injury—Bleomycin—skin cancer	0.000936	0.00766	CcSEcCtD
Caffeine—Infestation—Imiquimod—skin cancer	0.000933	0.00764	CcSEcCtD
Caffeine—Infestation NOS—Imiquimod—skin cancer	0.000933	0.00764	CcSEcCtD
Caffeine—RYR1—head—skin cancer	0.000932	0.00737	CbGeAlD
Caffeine—PIK3CA—head—skin cancer	0.000932	0.00737	CbGeAlD
Caffeine—Cardiac disorder—Vemurafenib—skin cancer	0.000912	0.00746	CcSEcCtD
Caffeine—PDE4B—nipple—skin cancer	0.000872	0.0069	CbGeAlD
Caffeine—Malnutrition—Vemurafenib—skin cancer	0.000855	0.007	CcSEcCtD
Caffeine—ATM—lymph node—skin cancer	0.000852	0.00674	CbGeAlD
Caffeine—Haemoglobin—Imiquimod—skin cancer	0.000842	0.00689	CcSEcCtD
Caffeine—Haemorrhage—Imiquimod—skin cancer	0.000838	0.00685	CcSEcCtD
Caffeine—Deafness—Temozolomide—skin cancer	0.000811	0.00664	CcSEcCtD
Caffeine—PRKDC—lymph node—skin cancer	0.000806	0.00638	CbGeAlD
Caffeine—Sepsis—Fluorouracil—skin cancer	0.000799	0.00654	CcSEcCtD
Caffeine—Immune system disorder—Imiquimod—skin cancer	0.000757	0.00619	CcSEcCtD
Caffeine—PIK3CD—lymph node—skin cancer	0.000756	0.00598	CbGeAlD
Caffeine—Malnutrition—Imiquimod—skin cancer	0.000729	0.00597	CcSEcCtD
Caffeine—Rash—Vismodegib—skin cancer	0.000712	0.00583	CcSEcCtD
Caffeine—Dermatitis—Vismodegib—skin cancer	0.000712	0.00582	CcSEcCtD
Caffeine—ADORA2A—lymphoid tissue—skin cancer	0.000708	0.0056	CbGeAlD
Caffeine—Infection—Vemurafenib—skin cancer	0.000693	0.00567	CcSEcCtD
Caffeine—ADORA2B—head—skin cancer	0.000686	0.00542	CbGeAlD
Caffeine—Nervous system disorder—Vemurafenib—skin cancer	0.000684	0.0056	CcSEcCtD
Caffeine—ADORA2A—female reproductive system—skin cancer	0.000683	0.0054	CbGeAlD
Caffeine—Skin disorder—Vemurafenib—skin cancer	0.000678	0.00555	CcSEcCtD
Caffeine—Agitation—Imiquimod—skin cancer	0.00067	0.00548	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.000669	0.00547	CcSEcCtD
Caffeine—Dry skin—Temozolomide—skin cancer	0.000665	0.00544	CcSEcCtD
Caffeine—PIK3CB—lymph node—skin cancer	0.000659	0.00522	CbGeAlD
Caffeine—PIK3CA—lymph node—skin cancer	0.000653	0.00516	CbGeAlD
Caffeine—Irritability—Fluorouracil—skin cancer	0.000638	0.00522	CcSEcCtD
Caffeine—Convulsion—Imiquimod—skin cancer	0.000632	0.00517	CcSEcCtD
Caffeine—Hypertension—Imiquimod—skin cancer	0.00063	0.00515	CcSEcCtD
Caffeine—Dry skin—Fluorouracil—skin cancer	0.000613	0.00501	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000603	0.00493	CcSEcCtD
Caffeine—Haemoglobin—Bleomycin—skin cancer	0.000598	0.00489	CcSEcCtD
Caffeine—Haemorrhage—Bleomycin—skin cancer	0.000595	0.00487	CcSEcCtD
Caffeine—Pulmonary oedema—Docetaxel—skin cancer	0.000592	0.00484	CcSEcCtD
Caffeine—Infection—Imiquimod—skin cancer	0.000591	0.00484	CcSEcCtD
Caffeine—ADORA1—female reproductive system—skin cancer	0.00059	0.00466	CbGeAlD
Caffeine—Nervous system disorder—Imiquimod—skin cancer	0.000584	0.00478	CcSEcCtD
Caffeine—Tachycardia—Imiquimod—skin cancer	0.000581	0.00475	CcSEcCtD
Caffeine—Skin disorder—Imiquimod—skin cancer	0.000578	0.00473	CcSEcCtD
Caffeine—Sepsis—Docetaxel—skin cancer	0.000577	0.00472	CcSEcCtD
Caffeine—ADORA2A—head—skin cancer	0.000571	0.00451	CbGeAlD
Caffeine—Hyperglycaemia—Temozolomide—skin cancer	0.000566	0.00463	CcSEcCtD
Caffeine—Infestation NOS—Temozolomide—skin cancer	0.000559	0.00458	CcSEcCtD
Caffeine—Infestation—Temozolomide—skin cancer	0.000559	0.00458	CcSEcCtD
Caffeine—Deafness—Docetaxel—skin cancer	0.00054	0.00441	CcSEcCtD
Caffeine—CYP1A2—nipple—skin cancer	0.000536	0.00424	CbGeAlD
Caffeine—Dyspnoea—Imiquimod—skin cancer	0.000531	0.00434	CcSEcCtD
Caffeine—CYP1B1—connective tissue—skin cancer	0.00053	0.00419	CbGeAlD
Caffeine—CYP1A1—nipple—skin cancer	0.000528	0.00418	CbGeAlD
Caffeine—Infestation—Fluorouracil—skin cancer	0.000515	0.00422	CcSEcCtD
Caffeine—Infestation NOS—Fluorouracil—skin cancer	0.000515	0.00422	CcSEcCtD
Caffeine—Hypersensitivity—Vemurafenib—skin cancer	0.000514	0.00421	CcSEcCtD
Caffeine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000514	0.0042	CcSEcCtD
Caffeine—PDE4B—mammalian vulva—skin cancer	0.000509	0.00403	CbGeAlD
Caffeine—Haemoglobin—Temozolomide—skin cancer	0.000505	0.00413	CcSEcCtD
Caffeine—Haemorrhage—Temozolomide—skin cancer	0.000502	0.00411	CcSEcCtD
Caffeine—ADORA1—head—skin cancer	0.000493	0.0039	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000483	0.00395	CcSEcCtD
Caffeine—CYP1B1—skin of body—skin cancer	0.000479	0.00379	CbGeAlD
Caffeine—Cardiac disorder—Temozolomide—skin cancer	0.000466	0.00381	CcSEcCtD
Caffeine—Haemoglobin—Fluorouracil—skin cancer	0.000465	0.0038	CcSEcCtD
Caffeine—Haemorrhage—Fluorouracil—skin cancer	0.000463	0.00378	CcSEcCtD
Caffeine—Immune system disorder—Temozolomide—skin cancer	0.000453	0.00371	CcSEcCtD
Caffeine—PDE4B—lymphoid tissue—skin cancer	0.000452	0.00358	CbGeAlD
Caffeine—Dry skin—Docetaxel—skin cancer	0.000442	0.00362	CcSEcCtD
Caffeine—Rash—Vemurafenib—skin cancer	0.00044	0.0036	CcSEcCtD
Caffeine—Dermatitis—Vemurafenib—skin cancer	0.00044	0.0036	CcSEcCtD
Caffeine—Hypersensitivity—Imiquimod—skin cancer	0.000439	0.00359	CcSEcCtD
Caffeine—Malnutrition—Temozolomide—skin cancer	0.000437	0.00358	CcSEcCtD
Caffeine—PDE4B—female reproductive system—skin cancer	0.000436	0.00345	CbGeAlD
Caffeine—Infection—Bleomycin—skin cancer	0.00042	0.00344	CcSEcCtD
Caffeine—Agitation—Temozolomide—skin cancer	0.000402	0.00329	CcSEcCtD
Caffeine—Infection—Dactinomycin—skin cancer	0.000392	0.00321	CcSEcCtD
Caffeine—CYP1B1—lymphoid tissue—skin cancer	0.000388	0.00307	CbGeAlD
Caffeine—ABCB1—blood vessel—skin cancer	0.00038	0.003	CbGeAlD
Caffeine—Convulsion—Temozolomide—skin cancer	0.000379	0.0031	CcSEcCtD
Caffeine—Hypertension—Temozolomide—skin cancer	0.000377	0.00309	CcSEcCtD
Caffeine—Dyspnoea—Bleomycin—skin cancer	0.000377	0.00308	CcSEcCtD
Caffeine—Rash—Imiquimod—skin cancer	0.000375	0.00307	CcSEcCtD
Caffeine—Dermatitis—Imiquimod—skin cancer	0.000375	0.00307	CcSEcCtD
Caffeine—CYP1B1—female reproductive system—skin cancer	0.000374	0.00296	CbGeAlD
Caffeine—Infestation—Docetaxel—skin cancer	0.000372	0.00304	CcSEcCtD
Caffeine—Infestation NOS—Docetaxel—skin cancer	0.000372	0.00304	CcSEcCtD
Caffeine—Renal failure—Docetaxel—skin cancer	0.000366	0.00299	CcSEcCtD
Caffeine—PDE4B—head—skin cancer	0.000364	0.00288	CbGeAlD
Caffeine—CYP1A1—epithelium—skin cancer	0.000356	0.00281	CbGeAlD
Caffeine—Infection—Temozolomide—skin cancer	0.000354	0.0029	CcSEcCtD
Caffeine—Nervous system disorder—Temozolomide—skin cancer	0.00035	0.00286	CcSEcCtD
Caffeine—Convulsion—Fluorouracil—skin cancer	0.000349	0.00285	CcSEcCtD
Caffeine—Skin disorder—Temozolomide—skin cancer	0.000346	0.00283	CcSEcCtD
Caffeine—ADORA1—lymph node—skin cancer	0.000345	0.00273	CbGeAlD
Caffeine—CYP1A1—skin of body—skin cancer	0.000338	0.00268	CbGeAlD
Caffeine—Haemoglobin—Docetaxel—skin cancer	0.000336	0.00275	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—skin cancer	0.000334	0.00273	CcSEcCtD
Caffeine—Infection—Fluorouracil—skin cancer	0.000327	0.00267	CcSEcCtD
Caffeine—Nervous system disorder—Fluorouracil—skin cancer	0.000322	0.00264	CcSEcCtD
Caffeine—Tachycardia—Fluorouracil—skin cancer	0.000321	0.00262	CcSEcCtD
Caffeine—Dyspnoea—Temozolomide—skin cancer	0.000318	0.0026	CcSEcCtD
Caffeine—CYP1B1—head—skin cancer	0.000312	0.00247	CbGeAlD
Caffeine—Hypersensitivity—Bleomycin—skin cancer	0.000312	0.00255	CcSEcCtD
Caffeine—Cardiac disorder—Docetaxel—skin cancer	0.00031	0.00254	CcSEcCtD
Caffeine—CYP1A1—mammalian vulva—skin cancer	0.000309	0.00244	CbGeAlD
Caffeine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000308	0.00252	CcSEcCtD
Caffeine—Immune system disorder—Docetaxel—skin cancer	0.000302	0.00247	CcSEcCtD
Caffeine—Dyspnoea—Fluorouracil—skin cancer	0.000293	0.0024	CcSEcCtD
Caffeine—Malnutrition—Docetaxel—skin cancer	0.000291	0.00238	CcSEcCtD
Caffeine—Hypersensitivity—Dactinomycin—skin cancer	0.000291	0.00238	CcSEcCtD
Caffeine—CYP2C8—female reproductive system—skin cancer	0.000286	0.00226	CbGeAlD
Caffeine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000284	0.00232	CcSEcCtD
Caffeine—Rash—Bleomycin—skin cancer	0.000267	0.00218	CcSEcCtD
Caffeine—Dermatitis—Bleomycin—skin cancer	0.000266	0.00218	CcSEcCtD
Caffeine—CYP1A1—female reproductive system—skin cancer	0.000264	0.00209	CbGeAlD
Caffeine—Hypersensitivity—Temozolomide—skin cancer	0.000263	0.00215	CcSEcCtD
Caffeine—PDE4B—lymph node—skin cancer	0.000255	0.00202	CbGeAlD
Caffeine—CYP2C9—female reproductive system—skin cancer	0.000254	0.00201	CbGeAlD
Caffeine—Convulsion—Docetaxel—skin cancer	0.000252	0.00206	CcSEcCtD
Caffeine—Hypertension—Docetaxel—skin cancer	0.000251	0.00205	CcSEcCtD
Caffeine—CYP2E1—lymphoid tissue—skin cancer	0.00025	0.00198	CbGeAlD
Caffeine—Rash—Dactinomycin—skin cancer	0.000249	0.00203	CcSEcCtD
Caffeine—Hypersensitivity—Fluorouracil—skin cancer	0.000242	0.00198	CcSEcCtD
Caffeine—CYP2E1—female reproductive system—skin cancer	0.000241	0.00191	CbGeAlD
Caffeine—Infection—Docetaxel—skin cancer	0.000236	0.00193	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—skin cancer	0.000233	0.0019	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—skin cancer	0.000232	0.00189	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—skin cancer	0.00023	0.00189	CcSEcCtD
Caffeine—Rash—Temozolomide—skin cancer	0.000225	0.00184	CcSEcCtD
Caffeine—Dermatitis—Temozolomide—skin cancer	0.000225	0.00184	CcSEcCtD
Caffeine—CYP1A1—head—skin cancer	0.000221	0.00175	CbGeAlD
Caffeine—CYP1B1—lymph node—skin cancer	0.000219	0.00173	CbGeAlD
Caffeine—Dyspnoea—Docetaxel—skin cancer	0.000211	0.00173	CcSEcCtD
Caffeine—Rash—Fluorouracil—skin cancer	0.000207	0.0017	CcSEcCtD
Caffeine—Dermatitis—Fluorouracil—skin cancer	0.000207	0.00169	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000205	0.00168	CcSEcCtD
Caffeine—CYP2E1—head—skin cancer	0.000201	0.00159	CbGeAlD
Caffeine—CYP3A4—female reproductive system—skin cancer	0.000194	0.00153	CbGeAlD
Caffeine—CYP2D6—female reproductive system—skin cancer	0.000191	0.00151	CbGeAlD
Caffeine—ABCB1—epithelium—skin cancer	0.000185	0.00146	CbGeAlD
Caffeine—Hypersensitivity—Docetaxel—skin cancer	0.000175	0.00143	CcSEcCtD
Caffeine—ABCB1—mammalian vulva—skin cancer	0.00016	0.00127	CbGeAlD
Caffeine—CYP2D6—head—skin cancer	0.000159	0.00126	CbGeAlD
Caffeine—CYP1A1—lymph node—skin cancer	0.000155	0.00122	CbGeAlD
Caffeine—Rash—Docetaxel—skin cancer	0.00015	0.00122	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—skin cancer	0.000149	0.00122	CcSEcCtD
Caffeine—ABCB1—lymphoid tissue—skin cancer	0.000142	0.00113	CbGeAlD
Caffeine—ABCB1—female reproductive system—skin cancer	0.000137	0.00109	CbGeAlD
Caffeine—ABCB1—head—skin cancer	0.000115	0.000907	CbGeAlD
Caffeine—ABCB1—lymph node—skin cancer	8.03e-05	0.000635	CbGeAlD
Caffeine—PIK3CD—Innate Immune System—NRAS—skin cancer	3.3e-05	0.000197	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—NRAS—skin cancer	3.28e-05	0.000196	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—FOXO4—skin cancer	3.26e-05	0.000194	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CSPG4—skin cancer	3.23e-05	0.000193	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—FOXO4—skin cancer	3.23e-05	0.000193	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—NRAS—skin cancer	3.2e-05	0.000191	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTCH1—skin cancer	3.19e-05	0.00019	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SMO—skin cancer	3.19e-05	0.00019	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—ERCC2—skin cancer	3.19e-05	0.00019	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—NRAS—skin cancer	3.17e-05	0.000189	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—KRAS—skin cancer	3.16e-05	0.000188	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTCH1—skin cancer	3.16e-05	0.000188	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SMO—skin cancer	3.16e-05	0.000188	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SHH—skin cancer	3.15e-05	0.000188	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RASA1—skin cancer	3.13e-05	0.000187	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	3.12e-05	0.000186	CbGpPWpGaD
Caffeine—PIK3CB—Disease—TERT—skin cancer	3.11e-05	0.000185	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTGER4—skin cancer	3.11e-05	0.000185	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTGER4—skin cancer	3.07e-05	0.000183	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—IL6—skin cancer	3.05e-05	0.000182	CbGpPWpGaD
Caffeine—PRKDC—Immune System—NRAS—skin cancer	3e-05	0.000179	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.99e-05	0.000178	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SMO—skin cancer	2.99e-05	0.000178	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTCH1—skin cancer	2.99e-05	0.000178	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HRAS—skin cancer	2.96e-05	0.000176	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.95e-05	0.000176	CbGpPWpGaD
Caffeine—ATM—Cell Cycle—TP53—skin cancer	2.94e-05	0.000175	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CSPG4—skin cancer	2.92e-05	0.000174	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—HRAS—skin cancer	2.91e-05	0.000173	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTGER4—skin cancer	2.91e-05	0.000173	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—NRAS—skin cancer	2.88e-05	0.000172	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.87e-05	0.000171	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—KRAS—skin cancer	2.84e-05	0.000169	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.83e-05	0.000169	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL6—skin cancer	2.83e-05	0.000169	CbGpPWpGaD
Caffeine—PIK3CD—Disease—BRAF—skin cancer	2.82e-05	0.000168	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—KRAS—skin cancer	2.82e-05	0.000168	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—TP53—skin cancer	2.81e-05	0.000167	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—IL6—skin cancer	2.78e-05	0.000166	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—ERCC2—skin cancer	2.78e-05	0.000166	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—NRAS—skin cancer	2.76e-05	0.000165	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—KRAS—skin cancer	2.75e-05	0.000164	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—FOXO4—skin cancer	2.75e-05	0.000164	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—KRAS—skin cancer	2.73e-05	0.000163	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—FOXO4—skin cancer	2.71e-05	0.000162	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—HRAS—skin cancer	2.68e-05	0.00016	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PLIN2—skin cancer	2.62e-05	0.000156	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PLIN2—skin cancer	2.62e-05	0.000156	CbGpPWpGaD
Caffeine—PIK3CA—Disease—ERCC2—skin cancer	2.61e-05	0.000156	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SHH—skin cancer	2.6e-05	0.000155	CbGpPWpGaD
Caffeine—PRKDC—Immune System—KRAS—skin cancer	2.59e-05	0.000154	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RASA1—skin cancer	2.58e-05	0.000154	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—FOXO4—skin cancer	2.57e-05	0.000153	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—NRAS—skin cancer	2.52e-05	0.00015	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TERT—skin cancer	2.5e-05	0.000149	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—KRAS—skin cancer	2.48e-05	0.000148	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PLIN2—skin cancer	2.47e-05	0.000147	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SMO—skin cancer	2.47e-05	0.000147	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTCH1—skin cancer	2.47e-05	0.000147	CbGpPWpGaD
Caffeine—PIK3CB—Disease—BRAF—skin cancer	2.46e-05	0.000147	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TERT—skin cancer	2.45e-05	0.000146	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—TP53—skin cancer	2.45e-05	0.000146	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—HRAS—skin cancer	2.42e-05	0.000144	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—HRAS—skin cancer	2.4e-05	0.000143	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTGER4—skin cancer	2.4e-05	0.000143	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—KRAS—skin cancer	2.38e-05	0.000142	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—HRAS—skin cancer	2.34e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HRAS—skin cancer	2.32e-05	0.000138	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—IL6—skin cancer	2.31e-05	0.000138	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—IL6—skin cancer	2.3e-05	0.000137	CbGpPWpGaD
Caffeine—PIK3CD—Disease—PTGS2—skin cancer	2.28e-05	0.000136	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—NRAS—skin cancer	2.27e-05	0.000135	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PLIN2—skin cancer	2.27e-05	0.000135	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ENO2—skin cancer	2.2e-05	0.000131	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HRAS—skin cancer	2.2e-05	0.000131	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—ERCC2—skin cancer	2.19e-05	0.000131	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—NRAS—skin cancer	2.18e-05	0.00013	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TERT—skin cancer	2.18e-05	0.00013	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—KRAS—skin cancer	2.17e-05	0.000129	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TERT—skin cancer	2.16e-05	0.000129	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FOXO4—skin cancer	2.12e-05	0.000126	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CSPG4—skin cancer	2.11e-05	0.000126	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CSPG4—skin cancer	2.11e-05	0.000126	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—HRAS—skin cancer	2.11e-05	0.000126	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—NRAS—skin cancer	2.1e-05	0.000125	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL6—skin cancer	2.1e-05	0.000125	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.03e-05	0.000121	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HRAS—skin cancer	2.02e-05	0.000121	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—IL6—skin cancer	2.01e-05	0.00012	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CSPG4—skin cancer	1.99e-05	0.000119	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PTGS2—skin cancer	1.99e-05	0.000119	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ENO2—skin cancer	1.98e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—BRAF—skin cancer	1.98e-05	0.000118	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PLIN2—skin cancer	1.97e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—KRAS—skin cancer	1.95e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Disease—BRAF—skin cancer	1.94e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TP53—skin cancer	1.93e-05	0.000115	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—NRAS—skin cancer	1.92e-05	0.000115	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PTGS2—skin cancer	1.91e-05	0.000114	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—KRAS—skin cancer	1.87e-05	0.000112	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PLIN2—skin cancer	1.86e-05	0.000111	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PLIN2—skin cancer	1.84e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—HRAS—skin cancer	1.84e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—NRAS—skin cancer	1.83e-05	0.000109	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TERT—skin cancer	1.83e-05	0.000109	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CSPG4—skin cancer	1.83e-05	0.000109	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—NRAS—skin cancer	1.82e-05	0.000108	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TERT—skin cancer	1.81e-05	0.000108	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—KRAS—skin cancer	1.81e-05	0.000108	CbGpPWpGaD
Caffeine—PIK3CD—Disease—NRAS—skin cancer	1.78e-05	0.000106	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—BRAF—skin cancer	1.72e-05	0.000103	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.72e-05	0.000103	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TERT—skin cancer	1.72e-05	0.000102	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—BRAF—skin cancer	1.71e-05	0.000102	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NRAS—skin cancer	1.68e-05	9.99e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTGS2—skin cancer	1.67e-05	9.93e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HRAS—skin cancer	1.66e-05	9.89e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KRAS—skin cancer	1.66e-05	9.87e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HRAS—skin cancer	1.59e-05	9.5e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CSPG4—skin cancer	1.59e-05	9.49e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—IL6—skin cancer	1.59e-05	9.47e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—KRAS—skin cancer	1.58e-05	9.41e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PLIN2—skin cancer	1.58e-05	9.4e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTGS2—skin cancer	1.57e-05	9.35e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—KRAS—skin cancer	1.56e-05	9.33e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NRAS—skin cancer	1.55e-05	9.23e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—NRAS—skin cancer	1.55e-05	9.21e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—HRAS—skin cancer	1.54e-05	9.18e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—KRAS—skin cancer	1.53e-05	9.11e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—NRAS—skin cancer	1.53e-05	9.11e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CSPG4—skin cancer	1.5e-05	8.94e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CSPG4—skin cancer	1.49e-05	8.86e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL6—skin cancer	1.47e-05	8.79e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—BRAF—skin cancer	1.45e-05	8.66e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—NRAS—skin cancer	1.45e-05	8.62e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KRAS—skin cancer	1.44e-05	8.6e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ENO2—skin cancer	1.44e-05	8.56e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—BRAF—skin cancer	1.44e-05	8.56e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ENO2—skin cancer	1.43e-05	8.55e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TERT—skin cancer	1.42e-05	8.44e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HRAS—skin cancer	1.41e-05	8.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—BRAF—skin cancer	1.36e-05	8.1e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.36e-05	8.09e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ENO2—skin cancer	1.35e-05	8.07e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL6—skin cancer	1.35e-05	8.03e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—HRAS—skin cancer	1.34e-05	8e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KRAS—skin cancer	1.33e-05	7.94e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—KRAS—skin cancer	1.33e-05	7.93e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—HRAS—skin cancer	1.33e-05	7.93e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NRAS—skin cancer	1.32e-05	7.88e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—KRAS—skin cancer	1.31e-05	7.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTGS2—skin cancer	1.31e-05	7.83e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HRAS—skin cancer	1.3e-05	7.74e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL6—skin cancer	1.28e-05	7.66e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ERCC2—skin cancer	1.28e-05	7.62e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL6—skin cancer	1.27e-05	7.59e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CSPG4—skin cancer	1.27e-05	7.57e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—KRAS—skin cancer	1.24e-05	7.42e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NRAS—skin cancer	1.24e-05	7.41e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—IL6—skin cancer	1.24e-05	7.41e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ENO2—skin cancer	1.24e-05	7.4e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HRAS—skin cancer	1.23e-05	7.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NRAS—skin cancer	1.22e-05	7.27e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLIN2—skin cancer	1.22e-05	7.25e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.21e-05	7.19e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—NRAS—skin cancer	1.19e-05	7.11e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL6—skin cancer	1.17e-05	7e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ERCC2—skin cancer	1.15e-05	6.87e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KRAS—skin cancer	1.14e-05	6.78e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HRAS—skin cancer	1.13e-05	6.75e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HRAS—skin cancer	1.13e-05	6.74e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BRAF—skin cancer	1.12e-05	6.69e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HRAS—skin cancer	1.12e-05	6.66e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NRAS—skin cancer	1.08e-05	6.46e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—IL6—skin cancer	1.08e-05	6.46e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL6—skin cancer	1.08e-05	6.45e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO2—skin cancer	1.08e-05	6.45e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NRAS—skin cancer	1.07e-05	6.4e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KRAS—skin cancer	1.07e-05	6.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL6—skin cancer	1.07e-05	6.38e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.06e-05	6.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HRAS—skin cancer	1.06e-05	6.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KRAS—skin cancer	1.05e-05	6.26e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—KRAS—skin cancer	1.03e-05	6.12e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO2—skin cancer	1.02e-05	6.08e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL6—skin cancer	1.01e-05	6.04e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO2—skin cancer	1.01e-05	6.02e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CSPG4—skin cancer	9.8e-06	5.84e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.71e-06	5.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—skin cancer	9.66e-06	5.76e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—skin cancer	9.51e-06	5.67e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—skin cancer	9.33e-06	5.56e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—skin cancer	9.25e-06	5.51e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—skin cancer	9.24e-06	5.51e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—skin cancer	9.13e-06	5.44e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—skin cancer	9.1e-06	5.42e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—skin cancer	9.02e-06	5.38e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—skin cancer	8.92e-06	5.32e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—skin cancer	8.73e-06	5.21e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—skin cancer	8.71e-06	5.19e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO2—skin cancer	8.63e-06	5.15e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—skin cancer	8.54e-06	5.09e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—skin cancer	8.54e-06	5.09e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—skin cancer	8.36e-06	4.98e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ERCC2—skin cancer	8.34e-06	4.97e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ERCC2—skin cancer	8.33e-06	4.96e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—skin cancer	8.29e-06	4.94e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—skin cancer	8.21e-06	4.9e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—skin cancer	7.93e-06	4.73e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.9e-06	4.71e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ERCC2—skin cancer	7.87e-06	4.69e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—skin cancer	7.86e-06	4.69e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—skin cancer	7.86e-06	4.68e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—skin cancer	7.76e-06	4.63e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—skin cancer	7.66e-06	4.57e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—skin cancer	7.59e-06	4.52e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—skin cancer	7.52e-06	4.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—skin cancer	7.35e-06	4.38e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ERCC2—skin cancer	7.21e-06	4.3e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—skin cancer	7.05e-06	4.2e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—skin cancer	6.98e-06	4.16e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—skin cancer	6.91e-06	4.12e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—skin cancer	6.9e-06	4.11e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.75e-06	4.03e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—skin cancer	6.68e-06	3.98e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—skin cancer	6.66e-06	3.97e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—skin cancer	6.6e-06	3.94e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—skin cancer	6.53e-06	3.9e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—skin cancer	6.39e-06	3.81e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—skin cancer	6.32e-06	3.77e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ERCC2—skin cancer	6.28e-06	3.75e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—skin cancer	6.25e-06	3.73e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—skin cancer	6.07e-06	3.62e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—skin cancer	5.98e-06	3.57e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ERCC2—skin cancer	5.92e-06	3.53e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ERCC2—skin cancer	5.87e-06	3.5e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—skin cancer	5.39e-06	3.22e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—skin cancer	5.16e-06	3.07e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ERCC2—skin cancer	5.01e-06	2.99e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—skin cancer	5e-06	2.98e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—skin cancer	4.99e-06	2.98e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—skin cancer	4.94e-06	2.94e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—skin cancer	4.72e-06	2.81e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—skin cancer	4.32e-06	2.58e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ERCC2—skin cancer	3.87e-06	2.31e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—skin cancer	3.77e-06	2.25e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—skin cancer	3.55e-06	2.12e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—skin cancer	3.52e-06	2.1e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—skin cancer	3.01e-06	1.79e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—skin cancer	2.32e-06	1.38e-05	CbGpPWpGaD
